ACTS REFERRED TO
1. Council Directive 76/76890/385/EEC of 27 July 197620 June 1990 on the approximation of the laws of the Member States relating to cosmetic products (OJ L 262, 27.9.1976, p. 169), as amended by:
Council Directive 79/661/EEC of 24 July 1979 active implantable medical devices (OJ L 192, 31.7.1979189, 20.7.1990, p. 35);
Commission Directive 82/147/EEC of 11 February 1982 (OJ L 63, 6.3.1982, p. 26);
17).
2. Council Directive 82/36893/42/EEC of 17 May 1982 (OJ L 167, 15.6.1982, p. 1);
Commission Directive 83/191/EEC of 30 March 1983 14 June 1993 concerning medical devices (OJ L 109, 26.4.1983169, 12.7.1993, p. 25);
Commission1).
3. Directive 83/341/EEC of 29 June 1983 (OJ L 188, 13.7.1983, p. 15);
Commission Directive 83/496/EEC of 22 September 1983 (OJ L 275, 8.10.1983, p. 20);
98/79/EC of the European Parliament and of the Council Directive 83/574/EEC of 26of 27 October 1983 (OJ L 332, 28.11.1983, p. 38);
Commission Directive 84/415/EEC of 18 July 1984 1998 on in vitro diagnostic medical devices (OJ L 228, 25.8.1984331, 7.12.1998, p. 31);
1).
4. Commission Directive 85/391/EEC of 16 July 1985 (OJ L 224, 22.8.1985, p. 40);
Commission Directive 86/179/EEC of 28 February 1986 Decision 2002/364/EC of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (OJ L 138, 24.5.1986131, 16.5.2002, p. 40);
Commission Directive 86/199/EEC of 26 March 1986 (OJ L 149, 3.6.1986, p. 38);17), as amended by:
Commission Directive 87/137/EEC of 2 February 1987 (OJ L 56, 26.2.1987, p. 20);
Commission Directive 88/233/EEC of 2 March 1988 (OJ L 105, 26.4.1988, p. 11);
Council Directive 88/667/EEC of 21 Decision 2011/869/EU of 20 December 19882011 (OJ L 382, 31341, 22.12.19882011, p. 4663);
Commission Directive 89/174/EEC of 21 February 1989Decision 2009/886/EC of 27 November 2009 (OJ L 64, 8.3.1989, p. 10);
Council Directive 89/679/EEC of 21 December 1989 (OJ L 398, 30.12.1989318, 4.12.2009, p. 25);
Commission Directive 90/121/EEC of 20Decision 2009/108/EC of 3 February 19902009 (OJ L 71, 17.3.199039, 10.2.2009, p. 40);
Commission Directive 91/184/EEC of 12 March 1991 (OJ L 91, 12.4.1991, p. 59);
34).
5. Commission Directive 92/8/EEC of 182003/12/EC of 3 February 1992 (OJ L 70, 17.3.1992, p. 23);
Commission Directive 92/86/EEC of 21 October 1992 (OJ L 325, 11.11.1992, p. 18);
Council 2003 on the reclassification of breast implants in the framework of Directive 93/3542/EEC of 14 June 1993 concerning medical devices (OJ L 151, 23.6.199328, 4.2.2003, p. 32);
Commission Directive 93/47/EEC of 22 June 1993 (OJ L 203, 13.8.1993, p. 24);
43).
6. Commission Directive 94/322005/50/EC of 29 June 1994 (OJ L 181, 15.7.1994, p. 31);
Commission Directive 95/34/EC of 10 July 1995 (OJ L 167, 18.7.1995, p. 19);
Commission 11 August 2005 on the reclassification of hip, knee and shoulder joint replacements in the framework of Council Directive 96/41/EC of 25 June 1996 93/42/EEC concerning medical devices (OJ L 198, 8.8.1996210, 12.8.2005, p. 36);
Commission Directive 97/1/EC of 10 January 1997 (OJ L 16, 18.1.1997, p. 85);
41).
7. Commission Directive 97/18/EC of 17Decision 2010/227/EU of 19 April 1997 (OJ L 114, 1.5.1997, p. 43);
Commission Directive 97/45/EC of 14 July 1997 (OJ L 196, 24.7.1997, p. 77);
Commission Directive 98/16/EC of 5 March 1998 2010 on the European Databank on Medical Devices (Eudamed) (OJ L 77, 14.3.1998102, 23.4.2010, p. 44);
45).
8. Commission Directive 98/62/EC of 3 September 1998 (OJ L 253, 15.9.1998, p. 20);
Commission Directive 2000/6/EC of 29 February 2000 (OJ L 56, 1.3.2000, p. 42);
Commission Directive 2000/11/EC of 10 March 2000 (OJ L 65, 14.3.2000, p. 22);
Commission Directive 2000/41/EC of 19 June 2000 (OJ L 145, 20.6.2000, p. 25);
Commission Directive 2002/34/EC of 15 April 2002 (OJ L 102, 18.4.2002, p. 19);
Commission Directive 2003/1/EC of 6 January 2003 Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (OJ L 5, 10.1.2003212, 9.8.2012, p. 14);
Commission Directive 2003/16/EC of 19 February 2003 (OJ L 46, 20.2.2003, p. 24);
Directive 2003/15/EC3).
9. Regulation (EU) 2017/745 of the European Parliament and of the Council of 27 February 2003 (OJ L 66, 11.3.2003, p. 26);
Commission 5 April 2017 on medical devices, amending Directive 2003/80/EC of 5 September 2003 (OJ L 224, 6.9.2003, p. 27);
Commission Directive 2003/83/EC of 24 September 2003 (OJ L 238, 25.9.2003, p. 23);
Commission Directive 2004/87/EC of 7 September 2004 (OJ L 287, 8.9.2004, p. 4);
Commission Directive 2004/88/EC of 7 September 2004 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 287, 8.9.2004117, 5.5.2017, p. 5);
Commission Directive 2004/94/EC of 15 September 2004 (OJ L 294, 17.9.2004, p. 28);
Commission Directive 2004/93/EC of 21 September 2004 (OJ L 300, 25.9.2004, p. 13);
Commission Directive 2005/9/EC of 28 January 2005 (OJ L 27, 29.1.2005, p. 46);
Commission Directive 2005/42/EC of 201), as amended by:
Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2005 (OJ L 158, 21.6.2005, p. 17);
Commission Directive 2005/52/EC of 9 September 2005 (OJ L 234, 10.9.2005, p. 9);
Commission Directive 2005/80/EC of 21 November 2005 (OJ L 303, 22.11.2005, p. 32);
Commission Directive 2006/65/EC of 19 July 2006 (OJ L 198, 20.7.2006, p. 11);
Commission Directive 2006/78/EC of 29 September 2006 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (OJ L 271, 30.9.2006, p. 56);
Commission Directive 2007/1/EC of 29 January 2007 (OJ L 25, 1.2.2007, p. 9);
Commission Directive 2007/17/EC of 22 March 2007 (OJ L 82, 23.3.2007, p. 27);
Commission Directive 2007/22/EC of 17 April 2007 (OJ L 101, 18.4.2007, p. 11);
Commission Directive 2007/53/EC of 29 August 2007 (OJ L 226, 30.8.2007, p. 19);
Commission Directive 2007/54/EC of 29 August 2007 (OJ L 226, 30.8.2007, p. 21);
Commission Directive 2007/67/EC of 22 November 2007 (OJ L 305, 23.11.2007, p. 22);
Commission Directive 2008/14/EC of 15, 2024/1860, 9.7.2024, ELI: http://data.europa.eu/eli/reg/2024/1860/oj);
Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2008 (OJ L 42, 16.2.2008, p. 43);
Commission Directive 2008/42/EC of 3 April 2008 (OJ L 93, 4.4.2008, p. 13);
Commission Directive 2008/88/EC of 23 September 2008 (OJ L 256, 24.9.2008, p. 12);
Commission Directive 20082024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123/EC of 18 December 2008 (OJ L 340, 19.12.2008, p. 71);
Directive 2008/112/EC of of the European Parliament and of the Council of 16 December 2008 (OJ L 345, 23.12.2008, p. 68);
Commission Directive 2009/6/EC of 4 February 2009 (OJ L 36, 5.2.2009, p. 15);
Commission Directive 2009/36/EC of 16 April 2009 (OJ L 98, 17.4.2009, p. 31);
Commission Directive 2009/129/EC of 9 October 2009 and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95 (OJ L 267, 10.10.2009, p. 18);
Commission Directive 2009/130/EC of 12 October 2009 (OJ L 268, 13.10.2009, p. 5);
Commission Directive 2009/134/EC of 28 October 2009 (OJ L 282, 29.10.2009, p. 15);
Commission Directive 2009/159/EU of 16 December 2009 (OJ L 336, 18.12.2009, p. 29, 2024/568, 14.2.2024, ELI: http://data.europa.eu/eli/reg/2024/568/oj);
Regulation (EC) No 1223/2009EU) 2023/607 of the European Parliament and of the Council of 30 November 2009 (OJ L 342, 22.12.2009, p. 59);
Commission Directive 2009/164/EU of 22 December 2009 (OJ L 344, 23.12.2009, p. 41);
Commission Directive 2010/3/EU of 1 February 2010 (OJ L 29, 2.2.2010, p. 5);
Commission Directive 2010/4/EU of 8 February 2010 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices (OJ L 36, 9.2.201080, 20.3.2023, p. 21);
Commission Directive 2011/59/EU of 13 May 2011 (OJ L 125, 14.5.2011, p. 17);
24);
Regulation (EU) 2020/561 of the European Parliament and of the Council Directive 2011/84/EU of 20 September 2011 (OJ L 283, 29.10.2011, p. 36); and
Commission Implementing Directive 2012/21/EU of 2 August 2012 of 23 April 2020 amending Regulation (EU) 2017/745 on medical devices, as regards the dates of application of certain of its provisions (OJ L 208, 3.8.2012130, 24.4.2020, p. 8).
Directive 76/768/EEC will be repealed with effect from 11 July 2013 and will be replaced by 18).
10. Regulation (EC) No 1223/2009EU) 2017/746 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (OJ L 342, 22.12.2009, p. 59).
2. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 342, 22.12.2009117, 5.5.2017, p. 59176), as amended by:
Commission Regulation (EU) No 344/2013 of 4 April 2013 amending Annexes II, III, V and VI to Regulation (EC) No 1223/2009 of 2024/1860 of the European Parliament and of the Council on cosmetic products (OJ L 114, 25.4.2013, p. 1); and
Commission Regulation of 13 June 2024 amending Regulations (EU) No 483/2013 of 24 May 2013 amending Annex III to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (OJ L 139, 25.5.2013, p. 8).
3. Commission Directive 80/1335/EEC of 22 December 1980 on the approximation of the laws of the Member States relating to methods of analysis necessary for checking the composition of cosmetic products2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (OJ L 383, 31.12.1980, p. 27), as amended by Commission Directive 87/143/EEC of 10 February 1987 (OJ L 57, 27.2.1987, p. 56).
4. Commission Directive 82/434/EEC of 14 May 1982 on the approximation of the laws , 2024/1860, 9.7.2024, ELI: http://data.europa.eu/eli/reg/2024/1860/oj);
Regulation (EU) 2023/607 of the European Parliament and of the Member States relating to methods of analysis necessary for checking the composition of cosmetic products (OJ L 185, 30.6.1982, p. 1), as amended by Commission Directive 90/207/EEC of 4 April 1990 Council of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices (OJ L 108, 28.4.199080, 20.3.2023, p. 92).
5. Commission Directive 83/514/EEC of 27 September 1983 on the approximation of the laws 24);
Regulation (EU) 2022/112 of the European Parliament and of the Member States relating to methods of analysis necessary for checking the composition of cosmetic products (OJ L 291, 24.10.1983, p. 9).
6. Commission Directive 85/490/EEC of 11 October 1985 on the approximation of laws of the Member States relating to methods of analysis necessary for checking the composition of cosmetic products Council of 25 January 2022 amending Regulation (EU) 2017/746 as regards transitional provisions for certain in vitro diagnostic medical devices and the deferred application of conditions for in-house devices (OJ L 295, 7.11.198519, 28.1.2022, p. 30).
7. Commission Directive 93/73/EEC of 9 September 1993 on the methods of analysis necessary for checking the composition of cosmetic products (OJ L 231, 14.9.1993, p. 34).
8. Commission Directive 95/17/EC of 19 3).
11. Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 19952024 laying down detailedharmonised rules for the application of Council Directive 76/768/EEC as regards the non-inclusion of one or more ingredients on the list used for the labelling of cosmetic products (OJ L 140, 23.6.1995, p. 26), as amended by:
Commission Directive 2006/81/EC of 23 October 2006 (OJ L 362, 20.12.2006, p. 92); and
Act concerning the conditions of accession of the Czech Republic, the Republic of Estonia, the Republic of Cyprus, the Republic of Latvia, the Republic of Lithuania, the Republic of Hungary, the Republic of Malta, the Republic of Poland, the Republic of Slovenia and the Slovak Republic and the adjustments to the Treaties on which the European Union is founded on artificial intelligence and amending Regulations (EC) No 300/2008, (EU) No 167/2013, (EU) No 168/2013, (EU) 2018/858, (EU) 2018/1139 and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797 and (EU) 2020/1828 (Artificial Intelligence Act) (OJ L 236, 23.9.2003, p. 33).
Commission Directive 95/17/EC will be repealed with effect from 11 July 2013.
9, 2024/1689, 12.7.2024, ELI: http://data.europa.eu/eli/reg/2024/1689/oj).
12. Commission Directive 95/32/EC of 7 July 1995 relating to methods of analysis necessary for checking the composition of cosmetic products (OJ L 178, 28.7.1995, p. 20).
10. Commission Directive 96/45/EC of 2 July 1996 relating to methods of analysis necessary for checking the composition of cosmetic products (OJ L 213, 22.8.1996, p. 8).
11. Commission Decision of 8 May 1996 establishing an inventory and a common nomenclature of ingredients employed in cosmetic products Decision (EU) 2025/2371 of 26 November 2025 on the notice regarding the functionality and the fulfilment of the functional specifications of certain electronic systems included in the European Database on Medical Devices referred to in Article 34(1) of Regulation (EU) 2017/745 of the European Parliament and of the Council (OJ L 132, 1.6.1996, p. 1) as amended by Commission Decision 2006/257/EC (OJ L 97, 5.4.2006, p. 1, 2025/2371, 27.11.2025, ELI: http://data.europa.eu/eli/dec/2025/2371/oj).